Drugs and medical devices rarely come from the nonprofit world. There are more than 2,600 for-profit pharmaceutical companies in the United States, but only three nonprofits have products on the American market.
summing up what did and did not work in the seven years since it distributed devices for $50 apiece. The organization recounts meeting its goals: It expanded access to the device and introduced competition to the market and thus lowered prices.
“We went through the same process that a pharmaceutical company would go through to bring a new product,” said Tina Raine-Bennett, who became CEO after Hale. After the product, Liletta, launched in 2015, Medicines360 continued to broaden its approved usage. Today, it is approved for all women of reproductive age, not just those who had born children, and last fall the FDA extended its use for pregnancy prevention for up to eight years.
What’s more, from the time the device leaves the manufacturer to the time it enters a clinic, it passes through many supply-chain intermediaries. Wholesalers, for example, charge a fee typically based on the list price of a drug and prefer higher-cost drugs because they make more money. However, for clinics that have a high proportion of uninsured patients, Liletta’s low cost is still attractive.
Another barrier the nonprofit faces is its limited ability to raise funds. It doesn’t have funds that shareholders would bring, and traditional venture capitalists, focused on profits, are uninterested.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Samsung’s Galaxy Buds 2 Pro are over $50 off right nowAmazon’s 50-inch Fire TV Omni QLED has also hit a new low.
Consulte Mais informação »
| Saudi Arabia’s Aramco Considers Selling $50 Billion in SharesThe offering, likely on the Riyadh exchange, would be the largest in the history of capital markets. Similar previous plans have fallen through.
Consulte Mais informação »
Saudi Aramco considers selling $50 billion in sharesSaudi Aramco considers selling $50 billion in shares - WSJ
Consulte Mais informação »
If Anyone Knows Where to Find $50 Million, Ron DeSantis’s Super PAC Is LookingThe PAC has reportedly asked donors for a massive, last-ditch cash injection ahead of the second GOP debate, as it scales back its canvassing operations in several key states.
Consulte Mais informação »
Overdose-reversal drug Narcan to hit store shelves next weekThe nasal spray is expected to be sold for around $50 for a box of two doses.
Consulte Mais informação »